High dose and short-term streptokinase infusion in patients with pulmonary embolism: prospective with seven-year follow-up trial.
Jerjes-Sanchez C, Ramirez-Rivera A, Arriaga-Nava R, Iglesias-Gonzalez S, Gutierrez P, Ibarra-Perez C, Martinez A, Valencia S, Rosado-Buzzo A, Pierzo JA, Rosas E.
Jerjes-Sanchez C, et al.
J Thromb Thrombolysis. 2001 Dec;12(3):237-47. doi: 10.1023/a:1015227125177.
J Thromb Thrombolysis. 2001.
PMID: 11981107
Clinical Trial.
Risk factors for mortality and recurrence were: right ventricular global hypokinesis (p<0.0001), 6 hours or over between onset symptoms and streptokinase regimen (p=0.02), severe systolic pulmonary arterial hypertension (p=0.001) right ventricula …
Risk factors for mortality and recurrence were: right ventricular global hypokinesis (p<0.0001), 6 hours or over bet …